Clinical features and outcomes of patients with myositis associated-interstitial lung disease

T. Karampitsakos (Patras, Greece), O. Papaioannou (Patras, Greece), S. Chrysikos (Athens, Greece), M. Katsaras (Patras, Greece), G. Tsirikos (Patras, Greece), P. Tsiri (Patras, Greece), E. Zarkadi (Patras, Greece), P. Efthymiou (Patras, Greece), V. Sotiropoulou (Patras, Greece), N. Ntoulias (Patras, Greece), E. Malakounidou (Patras, Greece), A. Bellou (Patras, Greece), V. Tzilas (Athens, Greece), E. Bouros (Athens, Greece), F. Sampsonas (Patras, Greece), T. Karageorgas (Athens, Greece), K. Dimakou (Athens, Greece), D. Bouros (Athens, Greece), A. Tzouvelekis (Patras, Greece)

Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Karampitsakos (Patras, Greece), O. Papaioannou (Patras, Greece), S. Chrysikos (Athens, Greece), M. Katsaras (Patras, Greece), G. Tsirikos (Patras, Greece), P. Tsiri (Patras, Greece), E. Zarkadi (Patras, Greece), P. Efthymiou (Patras, Greece), V. Sotiropoulou (Patras, Greece), N. Ntoulias (Patras, Greece), E. Malakounidou (Patras, Greece), A. Bellou (Patras, Greece), V. Tzilas (Athens, Greece), E. Bouros (Athens, Greece), F. Sampsonas (Patras, Greece), T. Karageorgas (Athens, Greece), K. Dimakou (Athens, Greece), D. Bouros (Athens, Greece), A. Tzouvelekis (Patras, Greece). Clinical features and outcomes of patients with myositis associated-interstitial lung disease. 2246

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Clinical characteristics of anti-Jo-1-positive interstitial lung disease
Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new?
Year: 2019


Clinical features and prognosis of Chinese sarcoidosis patients.
Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management
Year: 2018

Clinical features of patients with sarcoidosis associated with Sjogren‘s syndrome
Source: Eur Respir J 2005; 26: Suppl. 49, 32s
Year: 2005

Eosinophilic lung disease: clinical features of 25 patients
Source: Eur Respir J 2006; 28: Suppl. 50, 237s
Year: 2006

Clinical features of interstitial lung disease in polymyositis and dermatomyositis
Source: Eur Respir J 2006; 28: Suppl. 50, 828s
Year: 2006

Rheumatoid arthritis-related interstitial lung disease (RA-ILD): Clinical, functional features, and variables associated poor initial prognosis in a chilean cohort
Source: Virtual Congress 2020 – Clinical aspects and new treatment strategies for rare interstitial lung diseases in adults and children
Year: 2020

Difference of the clinical characteristics and outcome between interstitial lung disease with dermatomyositis and idiopathic interstitial pneumonia
Source: International Congress 2017 – Lung function testing
Year: 2017

Clinical features and outcome of patients with acute exacerbation of interstitial pneumonia associated with collagen vascular disease
Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis
Year: 2010

Clinical features and outcome of COVID-19 pneumonia in haemodialysis patients
Source: Virtual Congress 2021 – Diagnosis and management of COVID-19
Year: 2021


Incidence, clinical manifestations and prognosis of cardiac sarcoidosis in patients with pulmonary sarcoidosis
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013


Clinical characteristics of patients with unclassifiable interstitial lung disease
Source: International Congress 2015 – New insights into IIPs
Year: 2015

The features of patients with sarcoidosis
Source: Eur Respir J 2002; 20: Suppl. 38, 436s
Year: 2002

Interstitial lung disease with ANCA-associated vasculitis (AAV-ILD): Clinical features and survival compared to patients with ILD associated with systemic sclerosis and IPF
Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key
Year: 2020

Clinical and morphological signs of liver damadge in patients with pulmonary sarcoidosis
Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders
Year: 2011

Clinical and functional characteristics of patients with unclassifiable interstitial lung diseases (uILD) from eurIPFreg.
Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020


The features of sarcoidosis in owerweight patients.
Source: Virtual Congress 2021 – Moving forward in various aspects of sarcoidosis
Year: 2021


The characteristics of mycobacterioses in patients with chronic lung diseases
Source: International Congress 2019 – Airway infection in COPD
Year: 2019

SW13,15,17 Clinical, radiological and pathological correlations in lung diseases
Source: Milan 2017 - Educational material
Year: 2017

Interstitial pneumonia with autoimmune features associated with myositis autoantibodies: clinical characteristics from a multicenter Latin-American cohort.
Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside
Year: 2019


Features of tuberculosis incidence and clinical forms for sarcoidosis patients
Source: Eur Respir J 2004; 24: Suppl. 48, 202s
Year: 2004